Market News
Market news
-
News Recipharm to acquire Mitim
Adds an important technology in the filling of injectable beta lactams with sales to the US and European markets. -
News Launch of Valid Insight provides support for market access
Valid Insight’s launch aims to meet the market access challenges facing new medicines, helping life science research to translate into real-world benefits for patients and society. -
News BMS completes sale of its HIV R&D portfolio to ViiV Healthcare
The agreements with ViiV Healthcare do not impact BMS’s marketed HIV medicines, including Reyataz, Evotaz, Sustiva and Atripla. -
News Mylan's ANDA for generic Advair Diskus accepted for filing by FDA
FDA provides GDUFA goal date of 28 March 28 2017 -
News Aptuit and Icagen agree to strategic alliance
Alliance to provide drug discovery customers access to industry leading ion channel and transporter technologies. -
News Endo launches Belbuca (buprenorphine) buccal film for chronic pain management
The first and only buprenorphine formulation developed with a dissolving film that is absorbed through the inner lining of the cheek for chronic pain management. -
News Perrigo furthers commitment to Ireland
Dublin headquarters central to European and global growth strategy. -
News Alcon expands leadership position in treating glaucoma through acquisition of Transcend Medical
Acquisition to add minimally-invasive glaucoma surgery (MIGS) device to pipeline, expanding Alcon's surgical presence in a new category to treat glaucoma. -
News MSD to create 200 new jobs in Carlow, Cork and Tipperary
Expansion reflects critical role of MSD’s Irish sites in wider global network. -
News Cipla completes acquisition of generic businesses in US
The acquisition of InvaGen Pharmaceuticals provides Cipla with about 40 approved ANDAs, 32 marketed products, and 30 pipeline products which are expected to be approved during the next 4 years. -
News Athenx announces major expansion, creating 1,400 jobs in Western New York
Athenex to invest $1.62 billion in drug discovery and advanced manufacturing partnership, creating 900 jobs in Dunkirk and 500 jobs in Buffalo during the next 10 years. -
News USPTO Granted Patent Protecting IntelGenx's Rizaport oral film for migraines
Patent protects the composition of Rizaport and will be listed in the Orange Book upon approval of the product by FDA. -
News Sartocon Slice 50: Sartorius Stedim Biotech presents a new small-scale crossflow device
Designed for use in biotechnological applications, especially for membrane screening and small-volume process development. -
News UK court rules against Lilly in Alimta vitamin regimen patent lawsuit
Lilly plans to seek permission to appeal the ruling. -
News Vetter wins two coveted awards
Leading CDMO is granted both the WorldStar Award for Vetter-Ject and a 2016 CMO Leadership Award. -
News US biotechs driving growth at Scottish CMO
Symbiosis Pharmaceutical Services has picked-up several new clients in North America, which has primarily been driven by companies looking for small-scale aseptic manufacturing capabilities to support clinical trials. -
News Pharmaceutical packaging industry leaders form the Matrix Alliance to help manufacturers speed breakthrough treatments to market
Compatibility and testing of nested container and closure systems to help pharmaceutical companies manufacture parenteral medicines. -
News Albumedix announces exclusive commercialization agreement with ThioLogics for its proprietary drug conjugation platform
Combining ThioLogics' site-specific conjugation chemistry with Albumedix's drug delivery platform enables the creation of next-generation albumin drug conjugates. -
News Sartorius presents new premium mechanical pipette Tacta
Responding to the needs of users in the laboratories, Sartorius presents a new range of mechanical pipettes with a perfectly balanced design offering reliability, accuracy and comfortable use. -
News Bottle gripper head solutions from ANVER address demanding manufacturing challenges
Pneumatic-powered bottling pick-up grab heads for use with major lines of new or replacement bottling machinery. -
News Sandoz strengthens its biosimilars portfolio with acquisition of Pfizer's biosimilar infliximab in EEA
Deal strengthens Novartis immunology portfolio which includes investigational biosimilars adalimumab, etanercept and rituximab. -
News CMA fines pharma companies £45 million
The CMA has fined a number of pharmaceutical companies for anti-competitive conduct and agreements in relation to the supply of paroxetine. -
News Qualicaps acquires Genix Industria Farmaceutica, Brazil’s leading hard capsule manufacturer
The acquisition allows the company to effectively expand its global presence from operating sites in Japan, Spain, Romania, Canada and the US, to include Brazil. -
News Bosch expands pharma solid seminar range
Practical trainings on globally trending topics. -
News Cherwell supports two microbiology events in Oxfordshire
These meetings will cover aspects of pharmaceutical cleanroom sporicidal disinfection and environmental monitoring best practice during manufacture of pharmaceuticals. -
News Recipharm takes the lead in serialisation challenge with €40m investment
The serialisation of licensed drug products will be a legal requirement for companies in the EU from early 2019. -
News Cigna implements value-base contract with Novartis for heart drug Entresto
The pay-for-performance agreement ties the financial terms to how well the drug improves the relative health of Cigna's customers. -
News Synlogic announces first industry collaboration with AbbVie to develop a new class of medicines designed to power the microbiome
Multi-year R&D collaboration with AbbVie focused on novel medicines for treatment of inflammatory bowel disease. -
News Pfizer names executive leadership team for combined organization upon close of proposed Allergan transaction
Pfizer will continue to manage its commercial operations through two distinct businesses — the innovative products business and the established products business — after the completion of the proposed transaction. -
News Fast lyophilisation of HPLC fractions
Genevac Series 3 HT Evaporator developed to provide a rapid, high-throughput alternative to freeze drying HPLC purification fractions. -
News MedinCell enters into a technology agreement for long-acting injectable products
MedinCell and Sandoz will develop and commercialize long-acting injectable products based on BEPO technology with a primary focus on oncology. -
News Microbix announces new product development program to help combat Zika virus
Using its established development platform and unique expertise in virology, Microbix intends to develop and launch a range of products to help combat the Zika virus. -
News API market to touch US$185.9 billion by 2020
Global API market driven by the rising abbreviated new drug applications and the growth in filing drug master files from several Indian firms, says Transparency Market Research. -
News Selvita opens new research site in Poznan
The initial laboratory space will amount to 5,500 sq. ft, which constitutes nearly 20% increase in Selvita laboratory space, compared to the current state with significant extension possibilities. -
News Bavarian Nordic enters research collaboration to develop MRSA vaccine
The collaboration will use Exaxion's computer-based technology to discover novel antigens. -
News Merck set to launch new version of fertility pens
EMA approves Merck's GONAL-f prefilled pen 2.0. -
News Rx-360 summary of WHO supplementary guidelines on GMP for HVAC systems for non-sterile pharmaceuticals
These guidelines primarily focus on recommendations for systems for manufactures of solid dosage forms. -
News Teva and AbCellera enter into agreement to discover rare monoclonal antibodies
Agreement further supports Teva’s novel biologics development program. -
News Genentech chosen as a 2016 FOYA category winner
Genentech has won the Process Innovation category for its large-scale, Cell Culture Biologics Drug Substance Plant 2 (CCP2) located in Vacaville, CA. -
News Food and pharma demand for green packaging transforms the flexible packaging coatings market
Price concerns regarding sustainable coatings will be countered by their environmental and durability benefits, finds Frost & Sullivan. -
News New drugs from Abbvie, Gilead, Intercept and Merck forecast to achieve blockbuster status by 2020
Annual ‘Drugs to Watch’ study spotlights seven emerging blockbusters poised to enter the market in 2016. -
News Juniper Pharma Services to reformulate Pharmaust candidate for Phase II trials
The CDMO will also manufacture 20,000 capsules of the reformulated monepantel solution for the Australian company -
News Catalent invests $4.6 million to further expand Asia-Pacific clinical trials hub in Singapore
Singapore site now provides full clinical supply services. -
News Lonza to build capabilities for drug product development services
Capabilities will focus on parenteral dosage forms for biologics, drug conjugates, peptides and small molecules for products for injection or infusion. -
News Sanofi Pasteur to leverage its strong vaccine legacy in hunt for Zika vaccine
Building on the company's successful history in developing vaccines against similar viruses, most recently the introduction of Dengvaxia against dengue, Sanofi Pasteur is launching a Zika vaccine project. -
News BMS and Pfizer sign collaboration with Portola Pharmaceuticals to develop and commercialize investigational andexanet alfa in Japan
Andexanet alfa is designed to reverse the anticoagulant activity of Factor Xa inhibitors, including Eliquis (apixaban). -
News New chambers designed to provide optimum uniformity for stable environmental conditions
Thermo Scientific Environmental Chambers use a unique airflow system for advanced temperature control. -
News Aragen Bioscience announces ground breaking on state-of-the-art research facility
The new research space will add 15,000 sq.ft. to Aragen’s existing laboratories and will double capacity for diverse efficacy studies. -
News Sun Pharma launches imatinib mesylate in the US
Imatinib mesylate is the therapeutic equivalent to Novartis's Gleevec for indications approved by FDA. -
News CPHI announces new collaboration with the Africa Pharmaceutical Summit
This new collaboration will enhance the mission to provide a comprehensive platform to enable the growth of a quality African pharmaceutical industry that competitively contributes to the healthcare needs of Africans. -
News Allergan and AstraZeneca collaborate to develop and commercialize ATM-AVI for antibiotic-resistant gram-negative infections
ATM-AVI is an investigational, fixed-dose antibiotic combining aztreonam and avibactam. -
News Sanofi and the Iran Ministry of Health and Medical Education sign a Memorandum of Cooperation
Several projects will be studied to further develop existing local manufacturing collaborations and work on programs to fight chronic and non-communicable diseases. -
News Facility expansion at CRO following record year
Additional space will primarily be used to increase laboratory facilities, GMP suites and allocate space for storage of GMP materials. -
News AstraZeneca enters licensing agreement with China Medical System Holdings for hypertension medicine
Agreement for Plendil in China reinforces AstraZeneca’s focus on innovative medicines. -
News Merck announces new biopharma heads for North America and China
Gary Zieziula to head biopharma business in North America and Marc Horn to lead biopharma business in China. -
News Orbitrap Fusion Lumos Tribrid Mass Spectrometer wins Scientists’ Choice Award for Best New Drug Discovery Product of 2015
This award recognizes the company with the highest reviews and ratings on SelectScience. -
News Cherwell improves support for pharmaceutical microbiology in Republic of Ireland
Redipor prepared media to be supplied directly to customers. -
News Blend Therapeutics secures $38 million in Series C financing and changes name to Tarveda Therapeutics
Company to focus on pipeline of Pentarins as a unique and promising approach to treating solid tumour cancers. -
News Biological drugs market set to grow at a CAGR of 10.10% to reach US$287.1 billion by 2020
Transparency Market Research has announced the publication of a new report, titled "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020". -
News Sartorius Stedim Biotech launches Integrated Solutions online resource center
New website will support clients in developing and implementing entire single-use bioprocesses. -
News Albumedix and Eleven Biotherapeutics announce albumin variant technology agreement
Albumedix strengthens its leading position in albumin-based drug delivery through acquisition of Eleven's Supermin albumin technology. -
News Novozymes separates its biopharma activities to form independent company
The new stand-alone company Albumedix will continue to develop albumin-based products and technologies for the pharmaceutical industry. -
News Fc receptor protein collection
Recombinant Fc Receptor proteins from AMSBIO are uniquely suitable for pharmaceutical research. -
News Colorcon acquires Paulaur Corporation’s pharmaceutical sugar spheres business
The addition of the Paulaur products complements Colorcon’s Suglets Sugar Spheres product line and enhances Colorcon’s position as a leading global supplier of sugar spheres for the development of multiparticulate dosages. -
News Shire completes acquisition of Dyax
The addition of Kalbitor and DX-2930 to Shire's portfolio strengthens its leadership position in hereditary angioedema. -
News Sartorius Stedim Biotech presents new crossflow filtration system for process development
The ideal solution for scaling studies and low volume ultra- and diafiltration operations. -
News Global pharmaceutical launches: ideal start for market access activities should be at least 18 months ahead of launch
Payer relationship activities are especially important to start early, according to Cutting Edge Information. -
News Merck launches Vivera in Latin America
A new Consumer Health brand for gastrointestinal upset, starting in January 2016 with Chile. -
News Trelleborg Sealing Solutions leverages LSR technology for transdermal and subcutaneous delivery systems
With the sophisticated developments in microneedle patches, injectors and pre-filled syringes come increasing opportunities for using liquid silicone rubber. -
News Treatment pipeline for COPD fails to address many unmet needs
The Chronic Obstructive Pulmonary Disease (COPD) treatment pipeline lacks innovation despite an influx of new therapies, says GBI Research. -
News Pall enters supply agreement with Kaneka for sale and technical support of KanCapA Protein A chromatography sorbent
The introduction of KANEKA KanCapA expands the portfolio of continuous bioprocessing and chromatography products offered by Pall. -
News Catalent to open new clinical supply facility in Japan
The facility will provide full-service solutions, including project management and clinical supply management, comparator sourcing, secondary packaging and labeling, clinical storage, distribution, and drug return and destruction. -
News Mylan launches generic Felbatol tablets
Recommended for monotherapy or adjunctive therapy in the treatment of partial seizures. -
News SGS announces expansion and integration of chemistry & microbiology testing offer following Canadian acquisition
Testing services for cosmeceuticals, natural health products and medical marijuana from facilities in Canada. -
News Kuehne + Nagel and GSK sign long-term global logistics partnership contract
Kuehne + Nagel to run the core business of transporting products from the raw materials supplier to trade customers for the leading global healthcare company. -
News Innova Biosciences introduces Thunder-Link PLUS
New improved antibody oligonucleotide conjugation kit. -
News Centauri Therapeutics to develop novel anti-infective therapeutics
Company has acquired Alphamer immuno-therapeutics platform technology. -
News Merck announces favorable English Court ruling on name use
Court says MSD breached an agreement with Merck by using "Merck" alone either as a trade mark or a name in the UK. -
News Benepali, the first etanercept biosimilar referencing Enbrel, approved in the EU
Biogen will manufacture and commercialize Benepali in the EU. -
News Datatrak's technology driven drug development (TD3) supports clinical trial industry transformation
Patient-focused models, improving adherence, and controlling costs all benefit from TD3. -
News Immunotherapy inside the cell: the new frontier of cancer therapy
Frost & Sullivan Partner Dorman Followwill comments on one of the disrupting forces that are transforming the healthcare markets. -
News Xbrane signs deal with Helvetic BioPharma for its lead ranibizumab biosimilar, Xlucane
The deal is based on milestone payments during 2016 and royalty payments per sold dose. Product launch is expected during 2017. -
News Snapshot of innovations in R&D targeting key applications of drug delivery technologies
Oral Route, pulmonary, topical, implantable, injectable, transdermal and transmucosal route analysis. -
News Boehringer Ingelheim and Arena Pharmaceuticals collaborate to advance research in schizophrenia
Collaboration partners to strengthen research in psychiatric diseases. -
News Apogenix strengthens US patent position for lead immuno-oncology candidate APG101
The so-called method of use patent covers the use of CD95 ligand inhibitors, such as APG101, for the treatment of glioblastoma. -
News Big data specialists could breathe life into the pharma sector
Increased hiring of big data experts and data scientists could help to revitalise the pharmaceutical sector, according to NonStop Recruitment. -
News ”Small Molecule API Contract Manufacturer Quality Benchmarking (2016)” — quality benchmarking reports now available
Suite of reports provide readers with a comprehensive assessment of biopharmaceutical CMO service quality across three key areas of outsourced manufacturing: small molecule, biologic and fill finish. -
News Perrigo initiates voluntary product recall in the US of children's guaifenesin grape liquid and guaifenesin DM cherry liquid
Recall due to a potential defect with the dosage cup. -
News Catalent Biologics announces research collaboration with Roche on SmartAG technology
Collaboration focuses on development of novel molecules using SMARTag technology to couple different therapeutic modalities. -
News Lonza expands single-use manufacturing capacity in Slough facility to meet customer demand
Lonza adds two 1000-L single-use bioreactor systems to its current mammalian manufacturing capacity. -
News Life sciences executive to join Patheon
Gilles Cottier to lead the company’s PDS business. -
News Parkinson's disease treatment pipeline is likely to meet many unmet needs
The treatment pipeline for Parkinson's disease offers a markedly more promising landscape from the current market, says GBI Research. -
News Global pharmaceutical packaging market 2016–2020 — market segmentation by product type, material type & packaging type
Research and Markets has announced the addition of the "Global Pharmaceutical Packaging Market 2016–2020" report to their offering. -
News Scholar Rock announces option exercised by Janssen in immuno-oncology collaboration focused on supracellular activation
Company generates unique monoclonal antibodies that selectively inhibit the supracellular activation of latent TGF-beta 1 in the immune system. -
News Shire to combine with Baxalta, creating the global leader in rare diseases
Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020. -
News Higher breast cancer rates will push treatment market beyond $17 billion by 2021
The global breast cancer therapeutics market will increase in value from $10.4 billion in 2014 to $17.2 billion by 2021, says GBI Research. -
News Recipharm appoints general manager for its new blow fill seal subsidiary in Kaysersberg, France
Yves Buelens has been the plant manager for the Kaysersberg facility since 2014. -
News Epigenomics receives FDA notification about status of pending approval decision for Epi proColon
Final approval of the company's application is subject to the resolution of minor outstanding topics, such as the use of appropriate language in the product labeling. -
News AmpliPhi acquires key bacteriophage assets from UK-based Novolytics
The assets will broaden AmpliPhi's IP portfolio and speed the development of its phage therapies -
News Safer, more effective drugs will push vasculitis treatment market value to $558 million by 2024
GlobalData report states that the leading driver of this growth will be the anticipated launches of five biologics for the treatment of various forms of vasculitis, including BMS's Orencia, J&J’s Remicade, GSK’s (GSK) Benlysta and Nucala, and Roche’s A... -
News Genomics and Vertex collaborate to identify target therapeutic pathways
Genomics’ proprietary statistical analysis tools and integrated multi-phenotype database to be used to support R&D at Vertex Pharmaceuticals. -
News Merck and Biocartis to collaborate on new liquid biopsy technology for RAS biomarker testing
Merck becomes first pharmaceutical company to collaborate with multiple diagnostic providers to support RAS biomarker testing. -
News Allergan acquires medical dermatology and aesthetic medicine company Anterios to expand neurotoxin pipeline
Acquisition adds global rights to novel NDSTM platform topical delivery technology and ANT-1207, investigational botulinum toxin type A product. -
News Takeda acquires US biologics manufacturing facility
Takeda intends to use the facility primarily for the manufacture of Entyvio (vedolizumab) and other biologic products. -
News Hospira issues a voluntary nationwide recall of one lot of magnesium sulfate in water for injection
Recall issued as a result of a customer reporting an incorrect barcode on the primary bag labeling. -
News IPS Partners with AdhereTech to develop the first Internet of Things (IOT) pill bottle
Thousands of patients now using "smart" AdhereTech pill bottle to improve medication adherence. -
News Novartis Pharmaceuticals collaborates with Qualcomm in digital innovation with the Breezhaler inhaler device to treat COPD
Novartis plans to launch the next generation connected Breezhaler in 2019. -
News MannKind and Sanofi to terminate Afrezza license and collaboration agreement
MannKind is now reviewing its strategic options for Afrezza -
News Face of dermatology industry changing; companies in global skin disease market extending products
Innovative therapies for some skin diseases have stimulated renewed interest in this market among major pharma companies. -
News Kalbe Farma and Kimia Farma to open raw materials plants in Indonesia
Indonesia is poised to become a production base for overseas and local manufacturers of medicines. -
News Acerus terminates Natesto agreement with Endo
Acerus's immediate focus is to find a new Natesto partner in the US. -
News Tribute Pharmaceuticals receives notice of Allowance for Canadian patent expanding Cambia use in migraine treatment
The issuance of the new patent will expand Tribute's intellectual property protection for Cambia, currently indicated in Canada for the treatment of acute migraine in adults over 18 years of age. -
News ZIM to expand its refrigerated container fleet
The expansion of the refrigerated container fleet will support the growing demand for ZIMonitor, ZIM's premium reefer cargo tracking service. -
News Merck, Pfizer and Syndax announce collaboration to evaluate combination of avelumab and entinostat in ovarian cancer
The three companies will collaborate to investigate safety, tolerability and preliminary efficacy of avelumab and entinostat in advanced ovarian cancer. -
News Takeda provides further information about its new business venture with Teva
The new business venture, to be owned 51% by Teva and 49% by Takeda, will consist of Teva Takeda Pharma and Teva Takeda Yakuhin. -
News New NIH-funded memory drug moves into Phase I clinical study
Collaboration between NIH and Tetra Discovery Partners leads to development of treatment that may affect cognition. -
News Rx-360 releases the Best Practices for Quality Agreements Guide
The Guide is intended to assist both customers and suppliers in efficiently managing the initiation, negotiation, implementation, and ongoing maintenance of quality agreements.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance